Brain zaps tuned to your wiring: a new hope for depression?
NCT ID NCT07753473
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study investigates whether transcranial magnetic stimulation (TMS), a non-invasive technique that uses magnetic pulses to stimulate brain areas, can influence the coupling between heart and brain activity in individuals with depressive tendencies. Participants will undergo brain scans and receive different types of TMS targeting personalized brain regions, while their brain and heart signals are recorded. The goal is to understand how targeted stimulation affects this heart-brain connection, which could inform future personalized treatments for depression.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcranial magnetic stimulation (TMS) targeting personalized brain regions
- What this could lead to
- If successful, this could pave the way for more personalized, non-invasive brain stimulation treatments for depression, potentially improving how the brain and heart communicate.
- What could go wrong
- This is an early-stage study with a small number of participants, so results may not apply broadly. TMS is generally safe but can cause mild discomfort or headache.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 一、Inclusion criteria for the depressed group: 1. Aged 18-30 years; 2. Recent feelings of low mood and presence of depressive symptoms; 3. Physically healthy, with no history of neurological disorders; 4. No participation in other neuromodulation experiments within the past month; 5. Normal hearing and normal (or corrected-to-normal) vision; 6. PHQ-9 score \> 5 and BDI-II score \> 13; 7. Avoidance of staying up late, alcohol consumption, and excessive caffeine intake prior to the experiment; 8. Able and willing to cooperate with the completion of scale assessments. 二、Inclusion criteria for healthy participants: (1) Aged 18-30 years; (2) No significant symptoms of depression and no history of neuropsychiatric disorders; (3) Physically healthy with no history of neurological disorders; (4) No participation in other neuromodulation experiments within the past month; (5) Normal hearing and normal (or corrected-to-normal) vision; (6) PHQ-9 score \< 5 and BDI-II score \< 13; (7) Avoidance of staying up late, alcohol consumption, and excessive caffeine intake prior to the experiment; (8) Able and willing to cooperate with the completion of scale assessments. Exclusion Criteria: 1. History of head trauma (including neurosurgery), stroke, elevated intracranial pressure, or other brain-related disorders; 2. History of epileptic seizures or family history of epilepsy; 3. Receipt of TMS or other neuromodulation stimulation within the past month; 4. Presence of intracranial or internal metallic foreign bodies, electrodes made of silver or gold, or metal prostheses; 5. Presence of devices potentially affected by TMS, such as pacemakers, drug pumps, cochlear implants, or implanted brain stimulators; 6. Severe or recent cardiac, pulmonary, or hematopoietic system disorders, or other neurological diseases; 7. Clinically diagnosed moderate-to-severe depressive disorder; 8. Substance abuse, alcohol dependence, etc.; 9. Current active suicidal ideation or suicidal behavior; Refusal to sign the informed consent form.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Xidian University
RECRUITINGXi'an, Shaanxi, 71000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can schools catch teen mental health struggles before they escalate?
- Can a smart algorithm keep depression from returning?
- Brain zapping gets personal: a new approach to treating depression and anxiety
- Faith-Based therapy aims to heal trauma in young women
- Could simple home workouts ease depression in afghan women?
- Antidepressants may rewire how the brain perceives control